Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmanex Inc.

Latest From Pharmanex Inc.

CBD Format – Spectrum Or Isolate? – Likely To Be Differentiator Tried In FDA Forum, Courts

Companies choosing between CBD options – namely broad- or full-spectrum hemp extracts or CBD isolate – need to appreciate the differences and potential legal implications, attorneys say.

United States Legal Issues

Red Yeast Rice History Offers Blueprint For Clearing CBD As Dietary Ingredient

Legal dispute between FDA and Pharmanex decided in 1999 could be precedent for using hemp-derived ingredients including CBD in supplements, even though CBD already has been authorized for clinical drug evaluation and for use in a drug, says attorney Miriam Guggenheim.

Dietary Supplements FDA

People in Brief

Baruch jumps to Schiff from Coca-Cola for chief commercial officer role; Perrigo adds Larson for supply chain security; Revo Biolabs’ Balbert retires again; researcher Bushnell leads NCCAM’s new pain program; USANA hires Smidt as R&D VP; Vega ambassadors head to Olympics.

BioPharmaceutical Consumer

People in Brief

Baruch jumps to Schiff from Coca-Cola for chief commercial officer role; Perrigo adds Larson for supply chain security; Revo Biolabs’ Balbert retires again; researcher Bushnell leads NCCAM’s new pain program; USANA hires Smidt as R&D VP; Vega ambassadors head to Olympics.

BioPharmaceutical Consumer
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
UsernamePublicRestriction

Register